SEC Form 4 · accession 0001628280-26-056366
BECTON DICKINSON & CO · BDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roland Goette
Officer — EVP and President, EMEA
Period of report
Aug 11, 2026
Accepted (ET)
Aug 12, 2026 · 5:27 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000010795
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 11, 2026 | S | 2,438 | $180.84 | D | 14,856 | D | |
| Common StockF3 | holding | — | — | — | 1,779 | I | GSIP Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Securities sold were common stock acquired through the Becton, Dickinson and Company Global Share Investment Program (the "GSIP").
- F2Holdings reflect the addition of dividends the reporting person received as part of the equity adjustment made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp.
- F3Represents shares of common stock held under the Becton, Dickinson and Company Global Share Investment Program (the "GSIP"). The information presented for the GSIP is as of August 3, 2026.